Lightinderm is not just a company offering light therapy programs to take care of your skin. They are also people committed to preserving the health and beauty of your skin. We are looking for concrete solutions against diseases that can affect its proper functioning. In this context, our teams regularly attend conferences and meetings. Here are the reports from these conferences and what to remember from them.
1/ The 50th annual meeting of the European Society for Research in Dermatology
What is the European Society for Dermatological Research (ESDR)?
This annual meeting brings together researchers and clinicians from around fifty countries. Their specialty: dermatology. They share the latest results from dermatological, clinical and translational research.
What is the purpose of these meetings?
They allow researchers and clinicians to present the latest data and ideas in skin research and investigative dermatology. These data are exchanged during conferences, satellite meetings, poster presentations and clinically oriented symposia.
These men and women all share the same aspiration: to contribute to a better understanding of skin homeostasis with a view to improving patient health. This concerns skin diseases and inflammatory disorders.
What happened at this meeting?
Psoriasis, atopic eczema and contact dermatitis are the most common inflammatory dermatoses. They have been the subject of numerous studies in Europe. The role of cytokines and other inflammatory mediators have been studied in particular. Cell-mediated immunity was also discussed. What must be remembered is the emergence of diagnostic and therapeutic innovations in dermatological practice, particularly in the areas of allergic skin diseases, autoimmune diseases and skin cancer.
How does Lightinderm fit into this process?
We designed a poster presenting photobiomodulation. This has proven effective in treating skin inflammation in different contexts. Our poster made it better known. It also revealed our latest research findings explaining the cellular mechanisms that govern its anti-inflammatory effect.
2/ International congress of toxicology 2022 16th ICT
What is the International Congress of Toxicology?
It is the largest and most prestigious toxicology conference.
What is the purpose of this conference?
This congress takes stock of the current state of toxicological science and regulations. Participating professionals share their thoughts on the developments and major achievements of recent years. The themes covered are those of next generations riskassessment approaches.
The idea is to replace animal studies with new methodologies in silico, in vitro and ex vivo.
Lightinderm encourages non-animal experimental models as part of fundamental research into the anti-inflammatory mechanisms of visible light and its effects on skin regeneration and immunoregulation.
How does Lightinderm fit into this framework?
This conference paid a lot of attention to young researchers and toxicologists at the start of their careers. It was therefore a unique opportunity for us to present our research work to a very large and diverse audience of scientists and toxicologists.
We were able to explain our latest results on the role of the transcription factor Nrf2 in red light's amelioration of skin inflammation induced by chemical exposure.
The Nrf2 factor coordinates the expression of hundreds of genes contributing to the maintenance of cellular homeostasis under conditions of chemical and oxidative stress. It plays a key role in protecting cells against numerous toxicological attacks. It is therefore interesting from a therapeutic point of view in the treatment of several pathologies. Activation of Nrf2 allows you to benefit from the anti-inflammatory effects of visible light.
3/ Immunotoxicology and Chemical Allergy Specialty Section (ITCASS) and European Research Group on Experimental Contact Dermatitis (ERGECD) 2022
What did Lightinderm do during this meeting?
We met academic leaders whose work inspires us in the fields of cell biology, immunotoxicology and dermatology. We spoke with experts about the immunoregulatory effect of visible light in pathological skin.
During an oral presentation, we were able to share our recent discoveries in the field of photobiomodulation. This is today considered a valuable tool in cosmetic and medical dermatology.